EN
登录

Standard Dental Labs收购 M&D Dental Arts;宣布 Bridge AI软件的目标上线日期为 12月 1日

Standard Dental Labs Acquires M&D Dental Arts; Announces December 1 Launch Target for Bridge AI Software

GlobeNewswire 等信源发布 2026-11-04 16:57

可切换为仅中文


ORLANDO, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) --

佛罗里达州奥兰多,2026年11月4日(环球新闻社)--

Standard Dental Labs Inc. (OTCQB: TUTH)

标准牙科实验室公司(OTCQB: TUTH)

(“SDL” or the “Company”) today announced the acquisition of all assets of

(“SDL”或“公司”)今日宣布收购全部资产

M&D Dental Arts, LLC, of Deltona, Florida

佛罗里达州德尔托纳的 M&D Dental Arts, LLC

, including its client base and accounts receivable. The acquired laboratory’s work will transition into SDL’s existing Orlando facility and is expected to double that laboratory’s current production output.

,包括其客户群和应收账款。被收购实验室的工作将转移至SDL现有的奥兰多设施,预计将使该实验室当前的生产产量翻倍。

Recent facility upgrades increased Orlando’s production capacity to nearly four times its previous level. Management expects substantial capacity to remain available after the M&D work is integrated, positioning the facility to accommodate further acquisitions and organic growth.

近期的设施升级使奥兰多工厂的产能提升至接近此前的四倍。管理层预计,在并购与整合(M&D)工作完成后,仍将保有充足的剩余产能,从而使该工厂能够为进一步的收购和内生性增长提供支撑。

One of M&D’s owners will continue supporting the acquired client base and training SDL’s existing staff on established protocols, helping preserve customer relationships and case requirements during the transition. M&D’s staff will not transfer to SDL.

M&D 的一位所有者将继续支持被收购的客户群,并就既定流程对 SDL 的现有员工进行培训,以帮助在过渡期间维持客户关系并满足案件要求。M&D 的员工不会转入 SDL。

“The Orlando upgrades gave us room to grow, and this acquisition puts more of that capacity to work,” said James D. Brooks, President and Chief Executive Officer of Standard Dental Labs Inc. “We expect M&D’s work to double our current Orlando output while leaving substantial room for additional business.

“奥兰多的升级为我们提供了增长空间,而此次收购将使更多产能得以利用。”Standard Dental Labs Inc. 总裁兼首席执行官詹姆斯·D·布鲁克斯表示。“我们预计,M&D 的业务将使我们在奥兰多的现有产量翻倍,同时仍为额外业务保留充足的空间。”

Having one of the owners support the transition will help our team carry forward the protocols and attention those dentists expect.”.

有一位所有者支持这一过渡,将有助于我们的团队贯彻那些牙医所期望的规程和细致关注。

Bridge Software Targeted for Company-Wide Launch by December 1

Bridge 软件目标于12月1日前在全公司范围内推出

SDL also announced that Bridge, its internally developed AI-driven customer relationship management and digital workflow platform, is undergoing live testing, with a company-wide launch anticipated by December 1, 2026.

SDL还宣布,其内部开发的由人工智能驱动的客户关系管理和数字工作流平台“Bridge”正在进行实时测试,预计将于2026年12月1日前在全公司范围内推出。

Developed in-house with cooperation from iTero and DS Core through their respective API platforms, Bridge uses AI to bring incoming work from multiple digital dentistry platforms into a single interface. It combines case information with available patient and client history to give dental technicians a more complete understanding of each case and the dental practice’s requirements..

Bridge 是在 iTero 和 DS Core 通过各自 API 平台提供协作的情况下内部开发的,它利用人工智能将来自多个数字牙科平台的工作流整合到一个统一的界面中。该系统将病例信息与现有的患者及客户历史记录相结合,使牙科技师能够更全面地了解每个病例的具体情况以及牙科诊所的需求。

The platform is designed to connect practices, laboratory teams and vendors while supporting more informed production decisions and more consistent, refined restorations. Its name reflects both its role as a bridge between systems and participants and the crowns and bridges produced by SDL’s laboratories..

该平台旨在连接诊所、实验室团队和供应商,同时支持更明智的生产决策以及更一致、更精细的修复体制作。其名称既反映了它作为系统与参与者之间桥梁的角色,也体现了SDL实验室所制作的牙冠和牙桥。

Bridge will initially remain exclusive to SDL’s operations. Dentists will be able to use it as an interface for submitting cases to SDL at no charge, both at launch and over the long term. The platform is also intended to give dentists access to real-time production information.

Bridge 最初将专用于 SDL 的运营。牙医可以将其作为向 SDL 提交病例的界面,无论是在推出时还是长期来看,均不收取任何费用。该平台还旨在让牙医能够访问实时生产信息。

“Bridge brings the information surrounding a case together so our technicians can work with a fuller picture of the patient and the client’s history,” Brooks said. “Our goal is to make sending work to SDL easier and give our team better tools to deliver a polished finished product. The case-submission interface will remain free for dentists.”.

“Bridge 将与病例相关的信息整合在一起,使我们的技术人员能够更全面地了解患者和客户的历史背景,”布鲁克斯表示。“我们的目标是让向 SDL 发送工作变得更加便捷,并为我们的团队提供更好的工具,以交付精良的成品。病例提交界面将对牙医保持免费。”

AI Design Module Under Development

AI设计模块正在开发中

SDL expects to complete Bridge’s next module, a 3D computer-aided design application for dental technicians, within the next three months. The module is being developed to use AI to create restoration designs from scratch, with experienced technicians supervising the process and guiding continued improvement through their feedback and completed cases..

SDL预计在未来三个月内完成Bridge的下一个模块,这是一款面向牙科技师的3D计算机辅助设计应用程序。该模块的开发旨在利用人工智能从头生成修复体设计,由经验丰富的技师监督整个过程,并通过他们的反馈和已完成病例指导持续改进。

The Company’s objective is to reduce dependence on costly design libraries while accelerating the design workflow and shortening turnaround times for dentists and patients. Although Bridge’s case-submission interface will remain free, future workflows may involve separate costs associated with intraoral scanners or other dental equipment..

公司的目标是减少对昂贵设计库的依赖,同时加速设计工作流程,缩短牙医和患者的周转时间。尽管 Bridge 的案例提交界面将继续免费,但未来的工作流程可能会涉及与口内扫描仪或其他牙科设备相关的单独费用。

“We are developing AI as a tool that works with the experience of our technicians and continues to improve with each case,” Brooks said. “By reducing reliance on expensive design libraries and speeding up the work involved in producing a restoration, we see an opportunity to improve both service and production economics as SDL grows.”.

“我们正在开发一种人工智能工具,它与我们技术人员的经验相结合,并随着每个案例的积累而持续改进,”布鲁克斯表示。“通过减少对昂贵设计库的依赖,并加速修复体制作过程中的相关工作,我们看到随着SDL的发展,在提升服务质量和优化生产经济效益方面都存在机遇。”

Together, the M&D acquisition, expanded Orlando capacity and continued development of Bridge advance SDL’s strategy of combining established dental laboratory customer relationships with shared production infrastructure and internally developed technology.

M&D的收购、奥兰多产能的扩张以及Bridge项目的持续开发,共同推进了SDL的战略,即将成熟的牙科实验室客户关系与共享生产基础设施及内部开发的技术相结合。

About Standard Dental Labs Inc.

关于标准牙科实验室公司

Standard Dental Labs Inc. is a dental laboratory company headquartered in Orlando, Florida, pursuing growth through the acquisition and development of independent dental laboratories. The Company’s strategy is to consolidate production into regional facilities supported by shared technology, equipment and technical expertise.

Standard Dental Labs Inc. 是一家总部位于佛罗里达州奥兰多的牙科实验室公司,致力于通过收购和开发独立牙科实验室实现增长。公司的战略是将生产整合到区域性设施中,并由共享的技术、设备和技术专业知识提供支持。

SDL’s current acquisition focus is Florida, with a broader strategy targeting major North American markets. Its common stock trades on the OTCQB under the symbol TUTH..

SDL目前的收购重点是佛罗里达州,其更广泛的战略目标是北美主要市场。其普通股在OTCQB市场交易,股票代码为TUTH。

Forward Looking Statements

前瞻性陈述

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding anticipated revenue growth, future acquisitions, integration efforts, scalability, financing initiatives, operational synergies, and long-term shareholder value. Forward-looking statements generally can be identified by words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “will,” “may,” “continue,” and similar expressions..

本新闻稿包含联邦证券法定义下的前瞻性陈述,包括有关预期收入增长、未来收购、整合工作、可扩展性、融资举措、运营协同效应和长期股东价值的陈述。前瞻性陈述通常可以通过“期望”、“打算”、“计划”、“相信”、“预计”、“将”、“可能”、“继续”等词语以及类似表述来识别。

These statements are based on current expectations, estimates, and assumptions that are subject to significant risks and uncertainties, many of which are beyond the Company’s control. Actual results may differ materially from those expressed or implied by such forward-looking statements due to a variety of factors, including integration risks, customer retention, operational performance, financing availability, regulatory considerations, market conditions, and other risks disclosed in the Company’s filings with the Securities and Exchange Commission and disclosures published through OTC Markets..

这些陈述基于当前的预期、估计和假设,而这些预期、估计和假设受到重大风险和不确定性的影响,其中许多风险超出了公司的控制范围。由于多种因素,实际结果可能与此类前瞻性陈述所明示或暗示的结果存在重大差异,这些因素包括整合风险、客户留存、运营绩效、融资可得性、监管考量、市场状况,以及公司在向美国证券交易委员会提交的文件中和通过OTC Markets发布的披露中所揭示的其他风险。

The Company’s Regulation A offering statement referenced herein does not constitute an offer to sell or the solicitation of an offer to buy securities except pursuant to the qualified offering circular. Any investment should be made only after careful review of the offering materials and risk factors contained therein..

本文所提及的公司A条例发行声明并不构成出售证券的要约或购买证券要约的招揽,除非依据经资格的发行通函。任何投资都应在仔细审阅发行材料及其中的风险因素之后进行。

Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Standard Dental Labs Inc. undertakes no obligation to update or revise forward-looking statements except as required by law.

提醒读者不要过度依赖前瞻性陈述,这些陈述仅反映其作出之日的情况。Standard Dental Labs Inc. 没有义务更新或修订前瞻性陈述,除非法律另有要求。

Investor & Media Contact

投资者与媒体联系人

Standard Dental Labs Inc.

标准牙科实验室有限公司

424 E Central Blvd, Suite 308, Orlando, FL 32801

佛罗里达州奥兰多市中央大道东424号308室,邮编32801

Phone: (407) 789-1923

电话:(407) 789-1923

Email:

电子邮件:

info@sdl.care

info@sdl.care

Investors:

投资者:

https://sdl.care/investors

https://sdl.care/investors

SOURCE:

来源:

Standard Dental Labs Inc.

标准牙科实验室有限公司